Real-world outcomes with avelumab + axitinib in patients with advanced renal cell carcinoma in Japan: subgroup analyses from the J-DART2 study by International Metastatic Renal Cell Carcinoma Database Consortium risk classification. - Furukawa, Junya; Kato, Taigo; Yamasaki, Toshinari; Monji, Keisuke; Tanaka, Toshiaki; Tsuchiya, Norihiko; Miyagawa, Tomoaki; Yaegashi, Hiroshi; Sano, Tomoyasu; Karashima, Takashi; Fujita, Kazutoshi; Hori, Jun-ichi; et al. (International Journal of Clinical Oncology, 2025)